Binge drinking, HIV/HPV co-infection risk, and HIV testing: Factors associated with HPV vaccination among young adults in the United States

Olusanya, Olayinka Olufunmilayo; Wigfall, Lisa T.; Rossheim, Matthew E.; Tomar, Aditi; Barry, Adam E.

doi:10.1016/j.ypmed.2020.106023

Cited by 7 publications

(8 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are now very conflicting data on the uptake of HPV vaccinations among SGMY. Similar to our study, SGMY in a much smaller sample found an HPV vaccination rate of 10% [ 21 ]. Yet, other researchers did find higher vaccination rates among SGMY compared to heterosexual peers [ 15 ].…”

Section: Discussionsupporting

confidence: 90%

“…These youth have significant histories of risk behaviors associated with HIV (multiple sexual partners without condoms and STIs), as well as out-of-home placements (that is, homelessness, incarceration, mental health hospitalization, and drug treatment). In contrast to recent studies of HPV vaccinations among young people [ 21 ], our sample also reflects sociodemographic factors characterizing those who become HIV infected: 2/3 of the youth are SGMY, and about 80% are African American or Latina/o/x. These life histories place the young people at risk for long-term negative health outcomes, including both HIV and HPV.…”

Section: Discussionmentioning

confidence: 99%

“…All SGMY in the U.S. are at risk for HIV [ 19 ], especially gay and bisexual men and those in urban inner-cities where there tend to be higher rates of new HIV cases [ 20 ]. Only 39.4% of youth had received the HPV vaccine, and only 59% had ever been tested for HIV [ 21 ]. An even more recent study [ 15 ], found rates half of the previous year-18.2% based on 2018 data from the same survey.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

HPV Vaccination among Sexual and Gender Minority Youth Living with or at High-Risk for HIV

et al. 2022

View full text Add to dashboard Cite

Background: Human papillomavirus (HPV) is epidemic among young people, especially those at highest risk of acquiring HPV-related cancers. Methods: Youth aged 14–24 years old (N = 1628) were recruited from 13 clinics, community agencies, and social media sites in Los Angeles, California, and New Orleans, Louisiana, that specialized in serving sexual and gender minority youths (SGMY), especially males at risk for HIV. A cross-sectional comparison of sociodemographic and risk histories of HPV vaccinated/unvaccinated youths was conducted using both univariate and multivariate regressions. Results: About half (51.9%) of youth were vaccinated, with similar percentages across states and across genders. Sexual and gender minority youths (SGMY, i.e., gay, bisexual, transgender, and non-heterosexual; 68.8%) and their heterosexual peers (15%) were equally likely to be vaccinated (54%), even though their risk for HPV-related cancers is very different. Vaccinations were higher among younger youth, those not using condoms, youth with greater education, that possessed a primary health care provider, and youth diagnosed with HIV. Vaccinations were lower among youth that were out-of-home due to mental health inpatient hospitalization, drug treatment, homelessness, or incarceration. Conclusions: Special programs are required to target youth experiencing multiple life stressors, especially out-of-home experiences, those with less education, and without the safety net of health insurance or a provider.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

HPV Vaccination among Sexual and Gender Minority Youth Living with or at High-Risk for HIV

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The 2017 Behavioral Risk Factor Surveillance System survey reports that the number of young adults 18–26 years who initiated (21%) or completed (18%) the HPV vaccination series was very low, particularly when compared with the Healthy People 2030 target of 80% for HPV vaccine uptake by ages 13–15 years ( 16 ). Therefore, within a college/university setting, it is likely that a significant number of sexually active young adults are unvaccinated.…”

Section: Role Of Sdoh Barriers In Decreasing Vaccination Rates Among Susceptible Young Adultsmentioning

confidence: 99%

“…Given their potentially greater propensity for unsafe, at-risk behavioral practices compared with other age groups, these young adults are vulnerable to HPV infections and therefore susceptible to HPV-associated cancers. The 2017 survey also indicates that 18–26 year-old men were least likely to be vaccinated ( 16 ). It is of concern that men who have sex with men or identify as gay or bisexual have an increased prevalence of HPV infection ( 17 ).…”

Section: Role Of Sdoh Barriers In Decreasing Vaccination Rates Among Susceptible Young Adultsmentioning

confidence: 99%

A Digital Personal Health Library for Enabling Precision Health Promotion to Prevent Human Papilloma Virus-Associated Cancers

Olusanya

Ammar

Davis

et al. 2021

Front. Digit. Health

View full text Add to dashboard Cite

Human papillomavirus (HPV) causes the most prevalent sexually transmitted infection (STI) in the United States. Sexually active young adults are susceptible to HPV, accounting for approximately 50% of new STIs. Oncogenic HPV subtypes 16 and 18 are associated with squamous intraepithelial lesions and cancers and are mostly preventable through prophylactic HPV vaccination. Accordingly, this study's objectives are to (1) summarize SDoH barriers and implication for low HPV vaccination rates among young adults (18–26 years), (2) propose a digital health solution that utilizes the PHL to collect, integrate, and manage personalized sexual and health information, and (3) describe the features of the PHL-based app. Through the application of novel techniques from artificial intelligence, specifically knowledge representation, semantic web, and natural language processing, this proposed PHL-based application will compile clinical, biomedical, and SDoH data from multi-dimensional sources. Therefore, this application will provide digital health interventions that are customized to individuals' specific needs and capacities. The PHL-based application could promote management and usage of personalized digital health information to facilitate precision health promotion thereby, informing health decision-making regarding HPV vaccinations, routine HPV/STI testing, cancer screenings, vaccine safety/efficacy/side effects, and safe sexual practices. In addition to detecting vaccine hesitancy, disparities and perceived barriers, this application could address participants' specific needs/challenges with navigating health literacy, technical skills, peer influence, education, language, cultural and spiritual beliefs. Precision health promotion focused on improving knowledge acquisition and information-seeking behaviors, promoting safe sexual practices, increasing HPV vaccinations, and facilitating cancer screenings could be effective in preventing HPV-associated cancers.

show abstract

The Relationship of Health-Related and Health-System Factors with Patient-Centered Communication, HPV-Related Knowledge, and Perceived Effectiveness of the HPV Vaccine

Tomar,

Harvey,

Meng

2024

American Journal of Health Education

View full text Add to dashboard Cite

Binge drinking, HIV/HPV co-infection risk, and HIV testing: Factors associated with HPV vaccination among young adults in the United States

Cited by 7 publications

References 45 publications

HPV Vaccination among Sexual and Gender Minority Youth Living with or at High-Risk for HIV

HPV Vaccination among Sexual and Gender Minority Youth Living with or at High-Risk for HIV

A Digital Personal Health Library for Enabling Precision Health Promotion to Prevent Human Papilloma Virus-Associated Cancers

The Relationship of Health-Related and Health-System Factors with Patient-Centered Communication, HPV-Related Knowledge, and Perceived Effectiveness of the HPV Vaccine

Contact Info

Product

Resources

About